Novartis (NVS) said Thursday it will expand its programs to find and treat patients with heart disease and cancer in "hard-to-reach" communities worldwide.

By 2030, three Novartis community health approaches focused on closing gaps in care for low-income, rural and other communities will almost triple to more than 30 countries, the company said.